Johnson & Johnson
Stocks making the biggest moves premarket: Bank of America, Boeing, Johnson & Johnson and more
Check out the companies making headlines before the bell. Bank of America — Shares rose about 2% after Bank of America reported first-quarter results that exceeded analysts’ expectations , due to stronger-than-expected net interest income and trading revenue. The bank’s quarterly earnings rose 11% to $7.4 billion, or 90 cents a share, while its revenue increased 5.9% […]
Read More
U.S. stock futures slide after S&P 500 posts back-to-back gains: Live updates
Investors need to practice patience amid a ‘very much intact bull market,’ says Oppenheimer It is essential for investors to practice patience and not got swept up in trepidation amid this period of heightened uncertainty, according to Oppenheimer. In a Monday note, Oppenheimer chief investment strategist John Stoltzfus reiterated his bullish stance on equities. “We […]
Read More
Earnings season ramps up next week with no certainty for Wall Street on trade
The roller-coaster ride the stock market has been on is unlikely to end next week, with earnings ramping up in an environment where investors, companies and consumers have absolutely no certainty as to what will happen next with trade. Wall Street is about to wrap up one of its wildest weeks of trading ever, that […]
Read More
Trump’s pharmaceutical tariffs could raise costs for patients, worsen drug shortages
A pharmacist collects medications for prescriptions at a pharmacy. Simon Dawson | Bloomberg | Getty Images President Donald Trump’s planned tariffs on pharmaceuticals imported into the U.S. could have wide-ranging consequences for drugmakers and American patients, some experts told CNBC. The duties could disrupt the complex pharmaceutical supply chain, drive up the prices of drugs […]
Read More
Pharmaceutical stocks fall as Trump doubles down on tariffs threat
The Lilly Biotechnology Center in San Diego, California, on March 1, 2023. Mike Blake | Reuters Shares of drugmakers fell on Wednesday after President Donald Trump doubled down on plans to impose tariffs on pharmaceuticals imported into the U.S. Shares of U.S.-based companies Eli Lilly, AbbVie, Bristol Myers Squibb and Regeneron all fell about 4% […]
Read More
Stocks making the biggest moves premarket: Levi Strauss, UnitedHealth, Marvell, Broadcom and more
Check out the companies making headlines before the bell. Levi Strauss — The jeans maker surged 11% after the company reiterated its full year outlook. However, Levi noted that that it excludes any impact from the White House’s tariffs. The company also posted first-quarter adjusted earnings of 38 cents per share, which was 52% higher […]
Read More
Trump’s tariffs are a new challenge for Big Pharma. Here are the best-positioned stocks
Long-standing trade agreements have largely sheltered the pharmaceutical industry from tariffs but President Donald Trump’s goal of bringing manufacturing back to the United States has put the industry in the administration’s crosshairs. Trump first floated the idea of imposing tariffs of as much as 25% on imported pharmaceuticals in mid-February. Since then, he has repeated […]
Read More
Stocks making the biggest moves midday: Tesla, Newsmax, Bloom Energy, On Holding, Roblox and more
Check out the companies making headlines in midday trading. Roblox — Shares popped 4% after the gaming platform announced a partnership with Google to scale immersive advertising through the launch of rewarded video ads, which rewards viewers with in-game benefits. Brands and agencies will be able to buy these advertisement slots through Google’s advertising solutions […]
Read More
Stocks making the biggest moves premarket: PVH, Johnson & Johnson, Newsmax, Shake Shack and more
Check out the companies making headlines in premarket trading. PVH Corp — The fashion stock soared about 16% on the back of stronger-than-expected earnings for the fourth quarter. The Calvin Klein and Tommy Hilfiger parent earned $3.27 per share, excluding items, on $2.37 billion in revenue, beating the consensus forecasts of analysts polled by LSEG […]
Read More
U.S. judge rejects Johnson & Johnson’s $10 billion baby powder settlement
The Johnson & Johnson logo displayed on a monitor. Sopa Images | Lightrocket | Getty Images A U.S. bankruptcy judge on Monday rejected Johnson & Johnson’s $10 billion proposal to end tens of thousands of lawsuits alleging that its baby powder and other talc products cause ovarian cancer, marking the third time the company’s bankruptcy strategy has failed in court. J&J has been […]
Read More